---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-206638"
form_type: "8-K"
ticker: "TMDX"
cik: "0001756262"
company_name: "TransMedics Group, Inc."
filed_at: "2022-07-29T23:59:59+00:00"
generated_at: "2026-06-24T07:01:31.207185+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# TransMedics enters $60M CIBC term loan facility, repays $35M OrbiMed debt

## Summary
- New $60M senior secured term loan borrowed in full on July 25, 2022, maturing in 5 years.
- Proceeds repaid $35M outstanding under OrbiMed credit agreement; balance for general corporate purposes.
- Interest at SOFR (floor 1.5%) + 2.00% or ABR + 1.00%, at company's option.
- Financial covenants require minimum liquidity (greater of $10M or trailing 4-month EBITDA burn) and minimum total net revenue (75% of plan).

## SEC filing metadata
- accession: 0001193125-22-206638
- form_type: 8-K
- ticker: TMDX
- cik: 0001756262
- company_name: TransMedics Group, Inc.
- filed_at: 2022-07-29T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1756262/000119312522206638/0001193125-22-206638-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1756262/000119312522206638/d361583d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-206638
- JSON: https://secwatch.observer/filing/0001193125-22-206638.json
- Plain text: https://secwatch.observer/filing/0001193125-22-206638.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.